Direct antiviral agents for hepatitis C and drug interaction risk: A retrospective cohort study with real and simulated data on medication interaction, prevalence of comorbidities and comedications.

Raquel Boff da CostaMarisa Boff CostaLarisse LongoDaniela Elisa MiottoGustavo Hirata DellaviaMatheus Trucollo MichalczukMario Reis Álvares-da-Silva

Published in: PloS one (2021)

Comorbidities and comedications are common in patients with hepatitis C, as are drug-drug interactions. Even when second generation drugs are used, the occurrence of drug-drug interactions still presents a significant risk.

Keyphrases

adverse drug
risk assessment
drug induced
healthcare
risk factors
electronic health record
big data
artificial intelligence